AddLife AB (publ) (LON:0REZ)

Market Cap	1.51B
Revenue (ttm)	742.38M
Net Income (ttm)	18.19M
Shares Out	n/a
EPS (ttm)	0.15
PE Ratio	82.87
Forward PE	n/a
Dividend	0.04 (0.02%)
Ex-Dividend Date	May 9, 2025

Volume	11,663
Average Volume	9,273
Open	170.70
Previous Close	168.01
Day's Range	165.88 - 170.70
52-Week Range	54.85 - 170.70
Beta	1.34
RSI	63.66
Earnings Date	Feb 5, 2025

About AddLife AB

AddLife AB (publ), together with its subsidiaries, provides equipment, consumables, and reagents primarily to healthcare sector, research, colleges, and universities, as well as the food and pharmaceutical industries. The company operates through Labtech and Medtech segments. The Labtech segment offers products, solutions, and services in the areas of diagnostics, and biomedical research and laboratory equipment for plastic consumables, cell biology, reagents, lab, and other instruments. The Medtech segment provides medical device products for ...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 1906
• Employees: 2,256
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0REZ

Financial Performance

In 2024, AddLife AB's revenue was 10.29 billion, an increase of 6.21% compared to the previous year's 9.69 billion. Earnings were 252.00 million, an increase of 32.63%.

Financial numbers in SEK